Cargando…

Carcinogenicity of Aspartame: Soffritti Responds

Detalles Bibliográficos
Autor principal:	Soffritti, Morando
Formato:	Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Sciences 2008
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430255/ http://dx.doi.org/10.1289/ehp.10881R

Ejemplares similares

Aspartame: Soffritti Responds
por: Soffritti, Morando
Publicado: (2007)

Acesulfame Potassium: Soffritti Responds
por: Soffritti, Morando
Publicado: (2006)

Carcinogenicity of Aspartame in Rats Not Proven
por: Magnuson, Bernadene, et al.
Publicado: (2008)

First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats
por: Soffritti, Morando, et al.
Publicado: (2006)

Aspartame Not Linked to Cancer
por: Abegaz, Eyassu G.
Publicado: (2007)

Life-Span Exposure to Low Doses of Aspartame Beginning during Prenatal Life Increases Cancer Effects in Rats
por: Soffritti, Morando, et al.
Publicado: (2007)

IARC Carcinogen Update
por: Rousseau, Marie-Claude, et al.
Publicado: (2005)

Listing Occupational Carcinogens
por: Freund, Alice
Publicado: (2005)

Occupational Carcinogens: ELF MFs
por: Mild, Kjell Hanson, et al.
Publicado: (2005)

Development of an HPLC Method with an ODS Column to Determine Low Levels of Aspartame Diastereomers in Aspartame
por: Ohtsuki, Takashi, et al.
Publicado: (2016)

Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
por: Maler, Victor, et al.
Publicado: (2023)

Thirdhand smoke: Genotoxicity and carcinogenic potential
por: Hang, Bo, et al.
Publicado: (2019)

In Vivo Cytogenetic Studies on Aspartame
por: AlSuhaibani, Entissar S.
Publicado: (2010)

Role of RNA modifications in carcinogenesis and carcinogen damage response
por: Verghese, Michelle, et al.
Publicado: (2022)

Aspartame: Sweetener with anti-inflammatory potential?
por: Pradhan, Sapna, et al.
Publicado: (2010)

Aspartame and cancer – new evidence for causation
por: Landrigan, Philip J., et al.
Publicado: (2021)

CAFOs: Thorne Responds
por: Thorne, Peter S.
Publicado: (2007)

Hormesis: Calabrese Responds
por: Calabrese, Edward J.
Publicado: (2010)

Experimental evaluation of antipyretic and analgesic activities of aspartame
por: Tandel, Kirtida R.
Publicado: (2011)

Experimental evaluation of antipyretic and analgesic activity of aspartame
por: Pradhan, Sapna, et al.
Publicado: (2011)

Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences
por: Newbould, Ella, et al.
Publicado: (2021)

Perspectives on recent reviews of aspartame cancer epidemiology
por: Goodman, Julie E., et al.
Publicado: (2023)

The NIEHS Responds to Hurricane Katrina
por: Schwartz, David A.
Publicado: (2005)

Infant Methemoglobinemia: Fewtrell Responds
por: Fewtrell, Lorna
Publicado: (2005)

Study Controls: Ashby Responds
por: Ashby, John
Publicado: (2005)

“Arsenic in Food”: Silbergeld Responds
por: Silbergeld, Ellen
Publicado: (2005)

“Broken Windows”: Frumkin Responds
por: Frumkin, Howard
Publicado: (2005)

Chemical Mixtures: Hayes Responds
por: Hayes, Tyrone B.
Publicado: (2006)

ICCVAM: Birnbaum and Stokes Respond
por: Birnbaum, Linda S., et al.
Publicado: (2010)

Polyethylene Terephthalate: Sax Responds
por: Sax, Leonard
Publicado: (2010)

The Weight of Evidence Does Not Support the Listing of Styrene as “Reasonably Anticipated to be a Human Carcinogen” in NTP's Twelfth Report on Carcinogens
por: Rhomberg, Lorenz R., et al.
Publicado: (2013)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
por: Wu, Chung-Chun, et al.
Publicado: (2018)

Cryptorchidism: Main et al. Respond
por: Main, Katharina M., et al.
Publicado: (2008)

Beef Production: Koneswaran and Nierenberg Respond
por: Koneswaran, Gowri, et al.
Publicado: (2008)

Synthetic Musk Compounds: Luckenbach Responds
por: Luckenbach, Till, et al.
Publicado: (2005)

Credibility of Scientists: Barrow and Conrad Respond
por: Barrow, Craig S., et al.
Publicado: (2006)

Ozone: Kinney et al. Respond
por: Kinney, Patrick L., et al.
Publicado: (2005)

The Precautionary Principle: Schütz and Wiedemann Respond
por: Schütz, Holger, et al.
Publicado: (2005)

Ceruloplasmin and Copper: Méndez and Araya Respond
por: Méndez, Marco, et al.
Publicado: (2005)

“Inert” and Active Ingredients: Séralini Responds
por: Séralini, Gilles-Eric
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3r7gc7g4dod2ejgqbk645qn4k9